Old Web
English
Sign In
Acemap
>
authorDetail
>
Michael Augustyniak
Michael Augustyniak
Immune system
Immunology
Medicine
Pharmacokinetics
Pharmacology
4
Papers
29
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Macrophage-specific chemokines induced via innate immunity by amino acid copolymers and their role in EAE.
2011
PLOS ONE
Joseph Kovalchin
Jeffrey Krieger
Michelle Genova
Norio Kawamoto
Michael Augustyniak
Kathryn H. Collins
Troy Bloom
Allyson Masci
Tara Hittinger
Ingrid Dufour
Jack L. Strominger
Eric Zanelli
Show All
Source
Cite
Save
Citations (9)
Safety, Pharmacokinetic, and Pharmacodynamic Evaluations of PI‐2301, a Potent Immunomodulator, in a First‐in‐Human, Single‐Ascending‐Dose Study in Healthy Volunteers
2011
The Journal of Clinical Pharmacology
Joseph Kovalchin
Jeffrey Krieger
Kathy Collins
Michelle Genova
Michael Augustyniak
Allyson Masci
Tony Avril
Gwenola Gandon
Alain Patat
Nicolas Fauchoux
Claire Toutin
Eric Lacoste
Uday Patel
Edward Mascioli
Eric Zanelli
Show All
Source
Cite
Save
Citations (8)
Results of a phase I study in patients suffering from secondary-progressive multiple sclerosis demonstrating the safety of the amino acid copolymer PI-2301 and a possible induction of an anti-inflammatory cytokine response
2010
Journal of Neuroimmunology
Joseph Kovalchin
Jeffrey Krieger
Michelle Genova
Kathy Collins
Michael Augustyniak
Allyson Masci
T. Hittinger
B. Kuca
Gilles Edan
C. Braudeau
M. Rimbert
Uday Patel
Edward Mascioli
Eric Zanelli
Show All
Source
Cite
Save
Citations (12)
Sa.98. Preclinical and Clinical Development of a Second Generation Peptide Copolymer for the Treatment of Multiple Sclerosis
2008
Clinical Immunology
Joseph Kovalchin
Jeffrey Krieger
Ingrid Dufour
Kathy Collins
Michelle Genova
Michael Augustyniak
Kristen Rafuse
Alain Patat
Uday Patel
Edward Mascioli
Eric Zanelli
Show All
Source
Cite
Save
Citations (0)
1